These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11302696)
1. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells. Guiducci C; Anglana M; Wang A; Bacchetti S Exp Cell Res; 2001 May; 265(2):304-11. PubMed ID: 11302696 [TBL] [Abstract][Full Text] [Related]
2. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres. McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756 [TBL] [Abstract][Full Text] [Related]
3. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts. Small MB; Hubbard K; Pardinas JR; Marcus AM; Dhanaraj SN; Sethi KA J Cell Physiol; 1996 Sep; 168(3):727-36. PubMed ID: 8816928 [TBL] [Abstract][Full Text] [Related]
4. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Goldkorn A; Blackburn EH Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715 [TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells. Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711 [TBL] [Abstract][Full Text] [Related]
6. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation. Sun B; Chen M; Hawks CL; Hornsby PJ Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628 [TBL] [Abstract][Full Text] [Related]
7. Strict control of telomerase activation using Cre-mediated inversion. Ungrin MD; Harrington L BMC Biotechnol; 2006 Feb; 6():10. PubMed ID: 16504006 [TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703 [TBL] [Abstract][Full Text] [Related]
9. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels. Cao Y; Huschtscha LI; Nouwens AS; Pickett HA; Neumann AA; Chang AC; Toouli CD; Bryan TM; Reddel RR Cancer Res; 2008 May; 68(9):3115-23. PubMed ID: 18451136 [TBL] [Abstract][Full Text] [Related]
10. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183 [TBL] [Abstract][Full Text] [Related]
12. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Fasching CL; Bower K; Reddel RR Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271 [TBL] [Abstract][Full Text] [Related]
13. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634 [TBL] [Abstract][Full Text] [Related]
14. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit. Toouli CD; Huschtscha LI; Neumann AA; Noble JR; Colgin LM; Hukku B; Reddel RR Oncogene; 2002 Jan; 21(1):128-39. PubMed ID: 11791183 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690 [TBL] [Abstract][Full Text] [Related]
16. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482 [TBL] [Abstract][Full Text] [Related]
17. Telomeric function of mammalian telomerases at short telomeres. Fakhoury J; Marie-Egyptienne DT; Londoño-Vallejo JA; Autexier C J Cell Sci; 2010 May; 123(Pt 10):1693-704. PubMed ID: 20427319 [TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation. Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Horikawa I; Barrett JC Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729 [TBL] [Abstract][Full Text] [Related]
20. Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells. Velicescu M; Yu J; Herbert BS; Shay JW; Granada E; Dubeau L Cancer Res; 2003 Sep; 63(18):5813-20. PubMed ID: 14522904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]